Detection of early onset carnitine palmitoyltransferase ii deficiency by newborn screening. Should cpt ii deficiency be a primary disease target?

Rachel Mador‐house, Zaiping Liu, Sarah Dyack

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Detection of early onset carnitine palmitoyltransferase ii deficiency by newborn screening. Should cpt ii deficiency be a primary disease target?'. Together they form a unique fingerprint.

Medicine & Life Sciences